EVO – Evotec SE
EVO — Price & Forward EBITDA
Forward EBITDA (M)
Float Short %
0.12
Margin Of Safety %
Put/Call OI Ratio
EPS Next Q Diff
EPS Last/This Y
-0.01
EPS This/Next Y
0.31
Price
2.42
Target Price
3.8
Analyst Recom
2.09
Performance Q
-22.68
Upside
-554.5%
Beta
1.93
Ticker: EVO
of 1
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2026-02-27 | EVO | 3.42 | N/A | N/A | 0 |
| 2026-03-02 | EVO | 3.3 | N/A | N/A | 0 |
| 2026-03-03 | EVO | 3.08 | N/A | N/A | 0 |
| 2026-03-04 | EVO | 3.28 | N/A | N/A | 0 |
| 2026-03-05 | EVO | 3.12 | N/A | N/A | 0 |
| 2026-03-06 | EVO | 3.08 | N/A | N/A | 0 |
| 2026-03-09 | EVO | 3.03 | N/A | N/A | 0 |
| 2026-03-10 | EVO | 2.66 | N/A | N/A | 0 |
| 2026-03-11 | EVO | 2.5 | N/A | N/A | 0 |
| 2026-03-12 | EVO | 2.43 | N/A | N/A | 0 |
| 2026-03-13 | EVO | 2.41 | N/A | N/A | 0 |
| 2026-03-17 | EVO | 2.47 | N/A | N/A | 0 |
| 2026-03-18 | EVO | 2.45 | N/A | N/A | 0 |
| 2026-03-19 | EVO | 2.45 | N/A | N/A | 0 |
| 2026-03-20 | EVO | 2.41 | N/A | N/A | 0 |
| 2026-03-23 | EVO | 2.38 | N/A | N/A | 0 |
| 2026-03-24 | EVO | 2.36 | N/A | N/A | 0 |
| 2026-03-25 | EVO | 2.52 | N/A | N/A | 0 |
| 2026-03-26 | EVO | 2.47 | N/A | N/A | 0 |
| 2026-03-27 | EVO | 2.42 | N/A | N/A | 0 |
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2026-02-27 | EVO | 3.41 | - | 88.8 | -0.66 |
| 2026-03-02 | EVO | 3.29 | - | 108.8 | -0.66 |
| 2026-03-03 | EVO | 3.07 | - | 109.9 | -0.66 |
| 2026-03-04 | EVO | 3.28 | - | 105.4 | -0.66 |
| 2026-03-05 | EVO | 3.12 | - | 109.2 | -0.66 |
| 2026-03-06 | EVO | 3.08 | - | 108.1 | -0.66 |
| 2026-03-09 | EVO | 3.03 | - | 110.9 | -0.66 |
| 2026-03-10 | EVO | 2.67 | - | 114.3 | -0.66 |
| 2026-03-11 | EVO | 2.50 | - | 113.0 | -0.66 |
| 2026-03-12 | EVO | 2.44 | - | 111.3 | -0.66 |
| 2026-03-13 | EVO | 2.32 | - | 112.4 | -0.66 |
| 2026-03-17 | EVO | 2.46 | - | 106.2 | -0.66 |
| 2026-03-18 | EVO | 2.45 | - | 106.5 | -0.66 |
| 2026-03-19 | EVO | 2.46 | - | 106.3 | -0.66 |
| 2026-03-20 | EVO | 2.43 | - | 106.8 | -0.66 |
| 2026-03-23 | EVO | 2.38 | - | 107.5 | -0.66 |
| 2026-03-24 | EVO | 2.35 | - | 108.1 | -0.66 |
| 2026-03-25 | EVO | 2.52 | - | 105.4 | -0.66 |
| 2026-03-26 | EVO | 2.46 | - | 106.2 | -0.66 |
| 2026-03-27 | EVO | 2.42 | - | 107.0 | -0.66 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2026-02-27 | EVO | 0.00 | -1.44 | 0.08 |
| 2026-03-02 | EVO | 0.00 | -1.88 | 0.08 |
| 2026-03-03 | EVO | 0.00 | -1.88 | 0.08 |
| 2026-03-04 | EVO | 0.00 | -1.88 | 0.08 |
| 2026-03-05 | EVO | 0.00 | -1.88 | 0.08 |
| 2026-03-06 | EVO | 0.00 | -1.88 | 0.08 |
| 2026-03-09 | EVO | 0.00 | -1.83 | 0.08 |
| 2026-03-10 | EVO | 0.00 | -1.83 | 0.08 |
| 2026-03-11 | EVO | 0.00 | -1.83 | 0.10 |
| 2026-03-12 | EVO | 0.00 | -1.83 | 0.10 |
| 2026-03-13 | EVO | 0.00 | -1.83 | 0.10 |
| 2026-03-17 | EVO | 0.00 | -1.86 | 0.10 |
| 2026-03-18 | EVO | 0.00 | -1.86 | 0.10 |
| 2026-03-19 | EVO | 0.00 | -1.86 | 0.10 |
| 2026-03-20 | EVO | 0.00 | -1.86 | 0.10 |
| 2026-03-23 | EVO | 0.00 | -2.11 | 0.10 |
| 2026-03-24 | EVO | 0.00 | -2.11 | 0.10 |
| 2026-03-25 | EVO | 0.00 | -2.11 | 0.12 |
| 2026-03-26 | EVO | 0.00 | -2.11 | 0.12 |
| 2026-03-27 | EVO | 0.00 | -2.11 | 0.12 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
Avg. EPS Est. Current Quarter
0.07
Avg. EPS Est. Next Quarter
Insider Transactions
Institutional Transactions
-2.11
Beta
1.93
Average Sales Estimate Current Quarter
239
Average Sales Estimate Next Quarter
215
Fair Value
Quality Score
39
Growth Score
26
Sentiment Score
86
Actual DrawDown %
90.9
Max Drawdown 5-Year %
-91.3
Target Price
3.8
P/E
Forward P/E
PEG
P/S
1.03
P/B
0.91
P/Free Cash Flow
EPS
-0.5
Average EPS Est. Cur. Y
-0.66
EPS Next Y. (Est.)
-0.35
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
-21.2
Relative Volume
0.35
Return on Equity vs Sector %
-47.2
Return on Equity vs Industry %
-27
EPS 1 7Days Diff
-0.1
EPS 1 30Days Diff
-0.13
EBIT Estimation
107
◆
EVO
Healthcare
$2.42
Swing / Pullback
Buy the dip on strong trends
WEAK
RSI
34.5
Range 1M
11%
Momentum Growth
Ride accelerating trends
WEAK
EPS Yr
59%
EPS NY
10%
52W%
4.5%
Long-Term Value
Quality companies, undervalued
WEAK
🟢 BUY
+57% upside
Upside
+57%
Quality
39
Evotec SESector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Employees: 4788
Evotec SE operates as a drug discovery and development company in the United States, Germany, France, the United Kingdom, Switzerland, and internationally. It operates in two segments, Shared R&D and Just Evotec Biologics. The company is developing pharmaceutical products in various therapeutic areas, such as oncology, autoimmune, cancer, diabetes, heart failure, immunology, pain and inflammation, infectious, kidney, liver, respiratory, fibrotic and metabolic disease, and rare diseases; central nervous system (CNS) and cardiometabolic diseases; and animal and women health. The company has collaboration agreements with Mass General Brigham and Joslin Diabetes Center focusing on cardiometabolic diseases; BMS antiviral; Novo Nordisk cell therapy; University of Oxford; German Cancer Research Center; University Hospital in Hamburg; University of Toronto, Harvard, and Yale; Johns Hopkins University; Ospedale San Raffaele (OSR); and National University of Singapore. It has a partnership with LAB282, LAB150, beLAB2122, beLAB1407, LAB eN², Danube Labs, VC Amplitude Ventures, LaB eN2, and 65LAB. The company serves pharma and biotechnology companies, academic institutions, patient advocacy groups, and venture capital. The company was formerly known as Evotec AG and changed its name to Evotec SE in April 2019. Evotec SE was incorporated in 1993 and is headquartered in Hamburg, Germany.
EVO
Latest News
—
Caricamento notizie per EVO…
stock quote shares EVO – Evotec SE Stock Price stock today
news today EVO – Evotec SE stock forecast ,stock prediction 2023 2024 2025
marketwatch EVO – Evotec SE yahoo finance google finance
stock history EVO – Evotec SE invest stock market
stock prices EVO premarket after hours
ticker EVO fair value insiders trading